Silvaco Group, Inc. financials

SVCO CIK 0001943289

Source: EDGAR filings · Built 2026-06-02T04:07:26Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2024
Free Cash Flow -34.52M -20.28M 841.00K
EBITDA -42.42M -38.99M 1.74M
Working Capital 7.67M 72.79M -4.11M
Net Debt -5.93M -17.92M -2.49M
Gross Margin 78.29% 79.82% 82.76%
Operating Margin -72.78% -67.49% 2.09%
Net Margin -65.34% -66.03% -0.58%
Return on Equity (ROE) -54.95% -39.37% -3.36%
Return on Assets (ROA) -33.60% -27.68% -0.77%
Current Ratio 1.20× 3.11× 0.84×
Debt-to-Equity 0.04× 0.02× 0.21×
Effective Tax Rate 7.70% -1.24% 161.96%
Cash Conversion Ratio 0.82× 0.50× -3.73×
Accruals Ratio -0.06× -0.14× -0.04×
SBC % of Revenue 17.15% 45.10% 0.00%
CapEx Coverage -54.86× -39.16× 3.48×
Free Cash Flow Per Share $-1.16 $-0.79 $0.04

Valuation Metrics

Concept FY 2025FY 2024FY 2024
P/S 1.99× 3.86×
P/B 1.67× 2.30×

Income Statement

Concept FY 2025FY 2024FY 2024
Revenue from Contract with Customer, Excluding Assessed Tax 63.06M 59.68M 54.25M
Cost of Goods and Services Sold 13.69M 12.04M 9.35M
Gross Profit 49.37M 47.64M 44.89M
Research and Development Expense 29.86M 20.74M 13.17M
Operating Expenses 95.27M 87.92M 43.76M
Operating Income (Loss) -45.90M -40.28M 1.13M
Income Tax Expense (Benefit) -3.44M 484.00K 826.00K
Net Income (Loss) Attributable to Parent -41.21M -39.40M -316.00K
Earnings Per Share, Basic $-1.39 $-1.53 $-0.02
Weighted Average Number of Shares Outstanding, Basic 29.74M 25.67M 20.00M
Earnings Per Share, Diluted $-1.39 $-1.53 $-0.02
Weighted Average Number of Shares Outstanding, Diluted 29.74M 25.67M 20.00M

Balance Sheet

Concept FY 2025FY 2024FY 2024
Cash and Cash Equivalents, at Carrying Value 9.01M 19.61M 4.42M
Assets, Current 46.08M 107.28M 20.89M
Assets 122.64M 142.34M 40.88M
Liabilities, Current 38.40M 34.49M 24.99M
Long-term Debt, Excluding Current Maturities 0
Liabilities 47.65M 42.26M 31.48M
Stockholders' Equity Attributable to Parent 74.99M 100.08M 9.40M
Common Stock, Shares, Outstanding 30.95M 28.53M 20.00M

Cash Flow Statement

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (SVCO CIK 0001943289), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

IMUX

Immunic, Inc.

SAM

THE BOSTON BEER COMPANY, INC.

BHF

Brighthouse Financial, Inc.